ACURA PHARMACEUTICALS (SMCAP: ACUR)





$4.56 0.06 (1.33%)
Turn On
KEY STATS
52-Week High Price
9.00
52-Week Low Price
4.00
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.19 B
P/E Ratio (TTM)
55.3
Diluted EPS (TTM)
0.15
Shares
42.97 M
Dividend Rate ($) / (%)
0.00/0.00
73%
27%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -16% - ACUR has underperformed the S&P 500 by 42%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
SANGAMO BIOSCIENCES INC (SGMO) $4.85 -  $0.09(1.89%)0.23 B
SPECTRUM PHARMACEUTICALS (SPPI) $4.36 -  $0.00(0.00%)0.21 B
BMP SUNSTONE CORP (BJGP) $5.05 -  $0.14(2.85%)0.21 B
IDENIX PHARMACEUTICALS (IDIX) $3.00 -  $0.05(1.69%)0.19 B
NOVAVAX INC (NVAX) $2.05 -  $0.04(1.91%)0.21 B
CYPRESS BIOSCIENCE INC (CYPB) $5.06 -  $0.08(1.61%)0.19 B
BIOTIME; INC (BTIM) $5.05 -  $0.06(1.20%)0.19 B
CYTOKINETICS INC (CYTK) $3.02 -  $0.04(1.31%)0.18 B
FLAMEL TECHNOLOGIES SA (FLML) $7.94 -  $0.26(3.45%)0.19 B
LIGHTLAKE THERAPEUTICS (LLTP) $0.60 -  $0.55(47.83%)0.10 B
STOCK ANALYSIS
Stock Analysis
PetMed Delivers (PETS, PETM, ALKS)
PetMed takes the hassle out of buying medicine for a pet. Learn why this stock makes a perfect addition to any dive...
ACUR RELATED HEADLINES
arrow
Acura Pharmaceuticals Reports Third Quarter 2009 Financial Results
Acura Pharmaceuticals Reports Third Quarter 2009 Financial Results

by GlobeNewswire 10/26/2009
arrow
Acura Pharmaceuticals Submits Acurox(R) Briefing Package to FDA
Acura Pharmaceuticals Submits Acurox(R) Briefing Package to FDA

by GlobeNewswire 8/6/2009
arrow
Acura Pharmaceuticals Reports Second Quarter 2009 Financial Results
Acura Pharmaceuticals Reports Second Quarter 2009 Financial Results

by GlobeNewswire 7/30/2009
arrow
Acura Pharmaceuticals Receives Preliminary Review Letter from FDA Regarding Acurox(r)
Acura Pharmaceuticals Receives Preliminary Review Letter from FDA Regarding Acurox(r)

by GlobeNewswire 6/23/2009
arrow
Acura Pharmaceuticals Reports First Quarter 2009 Financial Results
Acura Pharmaceuticals Reports First Quarter 2009 Financial Results

by GlobeNewswire 5/1/2009
arrow
Acura Pharmaceuticals, Inc. Names Garth Boehm, Ph.D. VP of Modified Release Dosage Form Development
Acura Pharmaceuticals, Inc. Names Garth Boehm, Ph.D. VP of Modified Release Dosage Form Development

by GlobeNewswire 3/26/2009
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1